Advertisement

Topics

Grünenthal Company Profile

10:53 EST 9th February 2016 | BioPortfolio

Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti Grünenthal sono commercializzati in oltre 80 Paesi e il numero delle filiali è in continua crescita. Grünenthal occupa circa 4.800 persone a livello mondiale, persone che hanno dato un grande contributo per il successo della Società.L'ulteriore consolidamento attraverso una ricerca innovativa è una parte integrante della politica della nostra Società. L'ambizione di Grünenthal è quella di essere una società leader nella Ricerca e Sviluppo in campi selezionati: l'area dolore è la nostra competenza core.

Location

Via Correggio, 43
Milano
20149
Italy

Contact

Phone: 39-02-43051
Fax: 39-02-430555
Email: dg@grunenthal.com


News Articles [14 Associated News Articles listed on BioPortfolio]

Therametrics und Grünenthal vereinbaren Zusammenarbeit

Stans (awp) - Das Biotechnologieunternehmen Therametrics und das deutsche Pharmaunternehmen Grünenthal GmbH vereinbaren eine Zusammenarbeit. Demnach darf Grünenthal die Therametrics-Software DRR 2.....

Grünenthal and Akashi ink deal on HT-100 Duchenne muscular dystrophy candidate

Grünenthal on Friday announced the joint global drug development program with USA-based Akashi Therapeutics…

Grünenthal receives Brazilian ANVISA certification for Tecnandina production plant in Ecuador

Family-owned German drugmaker Grünenthal Group says that its Tecnandina manufacturing plant in Ecuador…

Grünenthal, Nordic Bioscience and Argenta Discovery collaborate on fibrosis

German family-owned drugmaker Grünenthal, Denmark’s Nordic Bioscience and Argenta Discovery 2009,…

Grünenthal and Akashi to develop HT-100 to treat DMD patients

German pharmaceutical firm Grünenthal has entered a joint global drug development programme to develop US-based Akashi Therapeutics’ orally available small molecule drug candidate, HT-100, to treat...

Video Interview: Grünenthal Reveals Plans To Maintain Robust Growth Following Strong 2015

EC marketing authorization for Grünenthal's Zalviso

Grünenthal has received approval from the European Commission for Zalviso (sufentanil sublingual tablet…

Depomed acquires rights to Grünenthal’s cebranopadol

US drugmaker Depomed has entered into a definitive agreement to acquire the US and Canadian rights to…

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Grünenthal

Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti...

Gr?nenthal

Grünenthal GmbH

Nil

More Information about "Grünenthal" on BioPortfolio

We have published hundreds of Grünenthal news stories on BioPortfolio along with dozens of Grünenthal Clinical Trials and PubMed Articles about Grünenthal for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grünenthal Companies in our database. You can also find out about relevant Grünenthal Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record